FDA Approves New Kind of Drug for Schizophrenia
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the weight gain and sluggishness of current dopamine-focused drugs.
While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
New schizophrenia drug ‘could change the lives of millions of people’ - The US Food and Drug Administration has approved ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
When a rash broke out on the hand of a patient taking part in the trial of a promising schizophrenia drug, clinical investigator Greg Mattingly began to fret that it might be an allergic reaction.
A Coventry man who persistently harassed his neighbours has been jailed. Ranjit Sadra would knock on doors at 3am asking for money and would aggressively beg in the streets around Cheylesmore.
A head teacher has expressed concern at drug-dealing happening near a school in Coventry. Residents close to the school and Charterhouse museum say dealing frequently takes place in the area.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback